Stents can not solve all the problems, for patients with coronary heart disease, complete stent intervention is only the first step to recovery, coronary stenting treatment and care is equally important. First, intervention should always be based on drugs. In recent years, the development of cardiac interventional therapy has been rapid, but the interventional therapy is still to use drugs at the same time, because drugs are always the “cornerstone” of cardiac treatment. At present, there are many misunderstandings and blind spots in heart disease drug therapy, including excessive and insufficient medication. For example, a significant portion of arrhythmias are functional, and the disease itself does not cause serious cardiovascular and cerebrovascular events. The treatment does not require the use of drugs, but should focus on the intervention of triggering factors, such as avoiding fatigue, pay attention to diet and so on. However, the use of drugs for these functional arrhythmias is common in clinical practice, which is considered overmedication. With the emergence of new drugs, doctors should learn to “use old drugs and optimize new drugs”. In the treatment of chronic heart failure, for example, commonly used drugs include angiotensin-converting enzyme inhibitors, aldosterone antagonists, and beta-blockers. These three types of drugs can be called the “Golden Triangle” in the treatment of chronic heart failure, and if they can be used rationally, they can play a good therapeutic role. Even if new drugs are chosen, they should be used on the basis of these old drugs, or under the premise of ineffective use. At the same time for no obvious efficacy of drugs, such as diuretics, should avoid excessive use. Second, acute infarction early intervention is most effective Reperfusion therapy is the most important therapeutic measure for acute ST-segment elevation myocardial infarction. In the onset of 12 hours to open the occluded coronary artery, restore blood flow, can reduce the area of myocardial infarction, reduce death. The earlier the coronary artery is recanalized, the greater the benefit to the patient. Therefore, for all patients with acute ST-segment elevation myocardial infarction, the diagnosis must be made as soon as possible after consultation and the strategy of reperfusion therapy must be determined in time. Chest pain patients should be treated in a race against time Acute myocardial infarction, aortic coarctation and other acute myocardial infarction with acute chest pain as the main clinical manifestations of the acute and critical patients need to be diagnosed and treated in a timely manner, chest pain centers provide a rapid diagnostic and treatment channel, which significantly reduces the time of diagnosis of chest pain, reduces the time of reperfusion therapy for STEMI, shortens the length of hospitalization, and improves the patient’s quality of life and satisfaction with the consultation. Chest pain center has become one of the important symbols to measure the level of acute myocardial infarction treatment. IV. Defibrillator should be implanted to prevent sudden cardiac death Implantable cardioverter-defibrillator (ICD) is the most effective way to prevent and treat SCD, but the expensive price, insufficient awareness of doctors, and painful treatment easily cause psychological burden to patients, coupled with the complexity of implantation technology and follow-up process as well as the fact that ICD cannot eliminate arrhythmia from the root, have limited the promotion and application of ICD in China. V. Urgently need to strengthen the comprehensive development outside the technology With regard to the future development of coronary intervention in China, China’s coronary intervention has entered the “post-technology era”. In the future, we should strengthen the comprehensive development beyond the technology in order to maximize the health benefits of this technology to our people. First of all, secondary prevention of coronary heart disease should lead to primary prevention, and the incidence of coronary heart disease should be controlled from the root through publicity and education promoted by patients. Secondly, to strengthen the construction of green channel for acute coronary syndrome and improve the pre-hospital treatment capacity, so that a higher proportion of patients with acute myocardial infarction can have PCI in time. thirdly, at present, the development of various regions in China is not balanced, so we need to strengthen the exchanges and quality control in the future, so as to achieve the overall improvement of the level of coronary intervention in China. Fourth, it is even more critical to pay more attention to clinical research while steadily developing the number of PCI, so as to provide academic impetus for the long-term development of PCI.